New York, NY (PRWEB) November 04, 2015
Ambu-Trans, a leading provider of non-emergency medical transportation serving the greater New York metropolitan area, and Mobileye Aftermarket, a division of Mobileye N.V., the global leader in the development of vision and data analysis for Advanced Driver Assistance Systems and autonomous driving, announced today that Ambu-Trans will be installing the Mobileye Aftermarket collision avoidance system in its fleet of over 60 paratransit vehicles.
The Mobileye Aftermarket system provides collision prevention and mitigation by warning drivers of potential incidents before they happen. According to the National Highway Transportation and Safety Administration, 93% of accidents are due to human error. An alert system such as Mobileye can give a distracted driver the opportunity to avoid a collision or mitigate its severity.
“The safety of our drivers and passengers is of utmost importance.” said Neal Kalish, President of Ambu-Trans. “With its real-time alert system, Mobileye’s Aftermarket system is an important addition to our fleet safety program.”
The safety benefits of collision avoidance systems like Mobileye have been proven to reduce collisions and the injuries and fatalities involved.
The Mobileye Aftermarket solution includes forward collision warnings for vehicles and pedestrians, headway monitoring/following time, and lane departure alerts, as well as the ability to warn drivers when speed limits are exceeded.
“The Mobileye Aftermarket system is a real solution for fleets that recognize the benefit of adding a collision avoidance system to their existing vehicles,” said Michael Backman, General Manager, Mobileye Aftermarket USA.
Hear more about Ambu-Trans’ experience with the Mobileye Aftermarket collision avoidance system at the Vision Zero Fleets Forum on November 5, 2015 at Queens Theatre in Flushing Meadows Corona Park.
Ambu-Trans is among the leading providers of non-emergency medical transportation in the greater New York metropolitan area. Our focus is on consistently providing safe, timely and courteous service at exceptional levels. Ambu-Trans operates one of the newest vehicle fleets in the New York City area, and hires and trains exceptional drivers to meet the needs of all hospitals, dialysis clinics, medical facilities and the patients we serve.
About Mobileye N.V.
Mobileye N.V. is the global leader in the development of vision and data analysis for Advanced Driver Assistance Systems and autonomous driving. Our technology keeps passengers safer on the roads, reduces the risks of traffic accidents, saves lives and has the potential to revolutionize the driving experience by enabling autonomous driving. Our proprietary software algorithms and EyeQ® chips perform detailed interpretations of the visual field in order to anticipate possible collisions with other vehicles, pedestrians, cyclists, animals, debris and other obstacles. Mobileye’s products are also able to detect roadway markings such as lanes, road boundaries, barriers and similar items, as well as to identify and read traffic signs and traffic lights. Our products are or will be integrated into car models from 23 global automakers including BMW, Ford, General Motors, Nissan, Volvo, Audi and Hyundai. Our products are also available in the aftermarket.
This press release may contain certain forward-looking statements. Words such as “believes,” “intends,” “expects,” “projects,” “anticipates,” and “future” or similar expressions are intended to identify forward-looking statements. These statements are only predictions based on our current expectations and projections about future events. You should not place undue reliance on these statements. Many factors may cause our actual results to differ materially from any forward-looking statement, including the risk factors and other matters set forth in Mobileye’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 20-F for the year ended December 31, 2014. Mobileye undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as may be required by law.